Michael McDevitt
Analyst · Bank of America Merrill Lynch
Thank you, Chuck. I will be providing commentary on our financial statements on both a GAAP and non-GAAP basis, which is consistent with how management measures Cree’s results internally. However, non-GAAP results are not in accordance with GAAP and may not be comparable to non-GAAP information provided by other companies. Non-GAAP information should be considered as supplement to, and not a substitute for, financial statements prepared in accordance with GAAP. A reconciliation of the non-GAAP information to the corresponding GAAP measures for all quarters mentioned on this call is posted on our website, along with a historical summary of other key metrics. For the third quarter of fiscal 2015, revenue was $410 million, which was on the higher end of our targeted range of $395 million to $415 million. GAAP earnings were $700,000 or $0.01 per diluted share for the third quarter of fiscal 2015, and non-GAAP earnings were $25 million or $0.22 per diluted share. Non-GAAP earnings exclude $24 million of expense net of tax, or $0.21 per diluted share, from the amortization of acquired intangibles, asset retirement charges, fair value accounting on our Lextar investment and stock based compensation. GAAP earnings per share were below our targeted range, due primarily to the $2.2 million decline in fair value of our Lextar investment which was caused by a reduction in Lextar’s share price during the quarter. Q3 GAAP gross margins were 30.6% and non-GAAP gross margins were 31.4% which excludes $3.2 million of stock-based compensation. Operating expenses for Q3 were $124 million on a GAAP basis and $102 million on a non-GAAP basis, both of which were down sequentially and better than targeted. Non-GAAP operating expenses exclude approximately $13 million of stock based compensation expense, $7 million of charges from amortization of acquired intangibles and $2 million for asset retirement charges. Our non-GAAP operating income was $26 million, which was on the low end of our target range for the quarter. Our Q3 GAAP tax rate was 0% and our non-GAAP tax rate was 9% for the quarter, which was less than our 17% target for Q3. The Q3 tax rates are lower than targeted due to lower forecasted earnings for fiscal 2015. Our Q3 9% non-GAAP tax rate is different than our 0% GAAP tax rate due primarily to excluding the impact of our Lextar investment fair value reduction recorded during the quarter. We ended the quarter with $632 million in cash and investments, net of line of credit borrowings, a $48 million decrease sequentially. The sequential decrease was due primarily to spending $17 million to repurchase 1.9 million Cree shares and $50 million of capital expenditures, which was partially offset by $66 million of cash provided from operations. Q3 free cash flow was $16 million. During the first nine months of fiscal 2015, we have spent $390 million to repurchase 11.2 million Cree shares under our fiscal 2015 $550 million authorized share repurchase program. Days sales outstanding were 48 days which was similar to Q2 and in line with our 50-day plus or minus target range. During Q3, we reduced inventory by $33 million as part of our targeted inventory reduction plan. As a result, inventory days on hand improved 13 days, decreasing from 108 days at the end of December to 95 days at the end of March. We made excellent progress within the quarter at reducing inventory levels to get within our 90-day plus or minus target range. Property, plant, and equipment additions were $45 million and patent additions were $5 million in the third quarter. Capital spending in Q3 was lower than Q2 and in line with our lower spending plan for fiscal 2015. We target fiscal 2015 property, plant, and equipment spending to be $200 million plus or minus. At this time, we target Q4 revenue to be in a range of $420 million to $440 million, which is comprised of strong growth in lighting revenue led by higher commercial fixture sales, LED sales similar sequentially and incrementally higher Power and RF revenue. We target Q4 non-GAAP gross margins to increase slightly to 32%, plus or minus, and GAAP gross margins to be 31.3%, plus or minus. We target incremental lighting gross margin improvement from Q3 due to a more favorable product mix, while LED and Power and RF segment margins are targeted to be similar sequentially. Our GAAP gross margin targets include stock based compensation expense of approximately $3.3 million, while our non-GAAP targets do not. We are targeting Q4 operating expenses to increase $5 million sequentially due primarily to higher patent and litigation spending and higher sales commissions related to higher lighting revenue. Our GAAP operating expense targets include $13 million of noncash stock based compensation expense, $1 million of asset retirement charges, and $7 million of charges for amortization of acquired intangibles. We target our Q4 tax rate to be 9%. As a reminder, our tax rates will fluctuate based on overall earnings, the tax jurisdictions in which our income is actually earned and other tax benefits that may or may not become available to Cree in future periods. GAAP net income for Q4 is targeted to be between $4 million to $9 million. Based on an estimated 108.5 million diluted shares outstanding, our GAAP EPS target is between $0.04 and $0.08 per diluted share. Non-GAAP net income is targeted to be between $26 million to $31 million, or $0.24 to $0.28 per diluted share. Our Q4 targets are based on a number of factors that could vary, including overall demand, product mix, factory execution and the competitive environment. Our non-GAAP EPS targets exclude amortization of acquired intangibles, asset retirement charges, changes in the fair value of our Lextar investment, and noncash stock based compensation in the amount of $0.20 per share. Thank you. And I’ll now turn the discussion back to Chuck.